Lycia Therapeutics
Diana Li is a Scientist I at Lycia Therapeutics since March 2022. Prior to that, Diana held various roles at NGM Biopharmaceuticals from November 2014 to March 2022, starting as a Research Associate I and progressing to Senior Research Associate II. Before NGM, Diana worked at MicroConstants as an Analytical Scientist II and at UCSD Microcirculation Laboratory as a Research Intern. Diana Li holds a Bachelor of Science in Biochemistry and Cell Biology from UC San Diego.
This person is not in any offices
Lycia Therapeutics
1 followers
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.